Skip to main content
Signal8
Estepan Ian Michael profile photo

Ian Michael Estepan

CIK: 0001836254

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (6.9%)

Position reduction

Option Exercises (M)7 (24.1%)

Derivative conversions

Awards (A)6 (20.7%)

Compensation grants

Other (G, F, J, C, D, …)14 (48.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sarepta Therapeutics, Inc. logo
SRPT

Sarepta Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (29 total)

  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Sep 4, 2026
    Tax Payment(F)
    Direct
    24.8K shares at avg. $22.22$551K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 11, 2026
    Tax Payment(F)
    Direct
    1.1K shares at avg. $17.03$19K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 9, 2026
    Tax Payment(F)
    Direct
    583 shares at avg. $16.95$10K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 9, 2026
    Tax Payment(F)
    Direct
    1K shares at avg. $16.95$18K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 2, 2026
    Tax Payment(F)
    Direct
    3.3K shares at avg. $16.20$53K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 2, 2026
    Tax Payment(F)
    Direct
    875 shares at avg. $16.20$14K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 1, 2026
    Exercise(M)
    Direct
    8.1K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Feb 26, 2026
    Exercise(M)
    Direct
    5.4K shares at avg. $13.71$74K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Feb 26, 2026
    Exercise(M)
    Direct
    2.1K shares at avg. $13.71$28K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Feb 25, 2026
    Award(A)

    Performance Stock Units

    Direct
    1.9K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Dec 16, 2025
    Sale(S)
    Direct
    13.2K shares at avg. $22.31$294K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Sep 3, 2025
    Award(A)
    Direct
    50K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Sep 3, 2025
    Award(A)
    Direct
    93.9K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Aug 5, 2025
    Award(A)

    Performance Stock Units

    Direct
    6.3K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 10, 2025
    Award(A)
    Direct
    8.3K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 10, 2025
    Tax Payment(F)
    Direct
    2.9K shares at avg. $100.13$289K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 10, 2025
    Tax Payment(F)
    Direct
    1.1K shares at avg. $100.13$105K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 7, 2025
    Exercise(M)
    Direct
    5.5K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 7, 2025
    Tax Payment(F)
    Direct
    9.1K shares at avg. $103.70$943K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 7, 2025
    Tax Payment(F)
    Direct
    585 shares at avg. $103.70$61K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 6, 2025
    Exercise(M)
    Direct
    17.5K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 4, 2025
    Tax Payment(F)
    Direct
    1.4K shares at avg. $101.34$139K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 3, 2025
    Tax Payment(F)
    Direct
    557 shares at avg. $103.77$58K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Feb 11, 2025
    Award(A)

    Performance Restricted Stock Units

    Direct
    3.5K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Jan 29, 2025
    Exercise(M)
    Direct
    1.5K shares at avg. $12.00$18K

1-25 of 29

About Estepan Ian Michael

Estepan Ian Michael (SEC CIK 0001836254) files insider reports with the SEC as Chief Operating Officer of Sarepta Therapeutics, Inc. (SRPT).

Signal8 holds 17 ownership filings by Estepan Ian Michael, all Form 4s, filed between Sep 3, 2024 and Sep 8, 2026. Those filings report 29 transactions, from Aug 30, 2024 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Estepan Ian Michael's filings is in CAMBRIDGE, MA.

Recent filings by Estepan Ian Michael

  • Sep 4, 2026: Tax withholding of SRPT shares (Form 4, code F).
  • Mar 11, 2026: Tax withholding of SRPT shares (Form 4, code F).
  • Mar 9, 2026: Tax withholdings of SRPT shares (2 lines, Form 4, code F).
  • Mar 2, 2026: Tax withholdings of SRPT shares (2 lines, Form 4, code F).
  • Mar 1, 2026: Option exercise of SRPT shares (Form 4, code M).

Other insiders filing for Sarepta Therapeutics, Inc. (SRPT)

How to read Form 4 transaction codes